Clinical Trial

Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy

Study acronym: EIRENE
Recruiting
View on ClinicalTrials.gov →
Summary
Few data about the impact of emotional distress (ED) on treatment efficacy in patients with metastatic breast cancer (mBC) are available. Aim of this study is to assess the outcomes of patients with mBC receiving first-line treatment according to the presence of baseline ED.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-05-20; most recent amendment 2026-06-15.
Status change: Not Yet Recruiting → Recruiting 2025-06-25
Trial Details
NCT Number NCT06994377
Lead Sponsor European Institute of Oncology
Conditions Metastatic Breast Cancer
Enrollment 1,000 participants
Start Date 2025-06-25
Primary Completion 2029-06 (estimated)
Study Completion 2029-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-17